Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Möller

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|July 1, 2016
New Insights into Human 17β-Hydroxysteroid Dehydrogenase Type 14: First Crystal Structures in Complex with a Steroidal Ligand and with a Potent Nonsteroidal InhibitorNicole Bertoletti, Florian Braun, Mahalia Lepage, et al.
International Journal of Molecular Sciences|August 7, 2021
Common Muscle Metabolic Signatures Highlight Arginine and Lysine Metabolism as Potential Therapeutic Targets to Combat Unhealthy AgingJanina Tokarz, Gabriele Möller, Anna Artati, et al.
Chemico-Biological Interactions|April 28, 2019
Engineering aldo-keto reductase 1B10 to mimic the distinct 1B15 topology and specificity towards inhibitors and substrates, including retinoids and steroidsJoan Giménez-Dejoz, Susanne Weber, Álvaro Fernández-Pardo, et al.
Plos One|June 15, 2010
Species used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1Gabriele Möller, Bettina Husen, Dorota Kowalik, et al.
Chemico-Biological Interactions|March 22, 2017
Characterization of AKR1B16, a novel mouse aldo-keto reductaseJoan Giménez-Dejoz, Susanne Weber, Oleg A Barski, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 27, 2020
Homology modeling meets site-directed mutagenesis: An ideal combination to elucidate the topology of 17β-HSD2Christoph P Sager, Susanne Weber, Matthias Negri, et al.
Molecular Endocrinology (Baltimore, Md.)|June 29, 2002
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin DReinhold G Erben, Desi W Soegiarto, Karin Weber, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estroneGabriele Möller, Dominga Deluca, Christian Gege, et al.
Plos One|August 23, 2011
The pathologic effect of a novel neomorphic Fgf9(Y162C) allele is restricted to decreased vision and retarded lens growthOliver Puk, Gabriele Möller, Arie Geerlof, et al.
Journal of Medicinal Chemistry|November 14, 2012
Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosisSandrine Marchais-Oberwinkler, Kuiying Xu, Marie Wetzel, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|July 1, 2016
New Insights into Human 17β-Hydroxysteroid Dehydrogenase Type 14: First Crystal Structures in Complex with a Steroidal Ligand and with a Potent Nonsteroidal InhibitorNicole Bertoletti, Florian Braun, Mahalia Lepage, et al.
International Journal of Molecular Sciences|August 7, 2021
Common Muscle Metabolic Signatures Highlight Arginine and Lysine Metabolism as Potential Therapeutic Targets to Combat Unhealthy AgingJanina Tokarz, Gabriele Möller, Anna Artati, et al.
Chemico-Biological Interactions|April 28, 2019
Engineering aldo-keto reductase 1B10 to mimic the distinct 1B15 topology and specificity towards inhibitors and substrates, including retinoids and steroidsJoan Giménez-Dejoz, Susanne Weber, Álvaro Fernández-Pardo, et al.
Plos One|June 15, 2010
Species used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1Gabriele Möller, Bettina Husen, Dorota Kowalik, et al.
Chemico-Biological Interactions|March 22, 2017
Characterization of AKR1B16, a novel mouse aldo-keto reductaseJoan Giménez-Dejoz, Susanne Weber, Oleg A Barski, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 27, 2020
Homology modeling meets site-directed mutagenesis: An ideal combination to elucidate the topology of 17β-HSD2Christoph P Sager, Susanne Weber, Matthias Negri, et al.
Molecular Endocrinology (Baltimore, Md.)|June 29, 2002
Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin DReinhold G Erben, Desi W Soegiarto, Karin Weber, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2009
Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estroneGabriele Möller, Dominga Deluca, Christian Gege, et al.
Plos One|August 23, 2011
The pathologic effect of a novel neomorphic Fgf9(Y162C) allele is restricted to decreased vision and retarded lens growthOliver Puk, Gabriele Möller, Arie Geerlof, et al.
Journal of Medicinal Chemistry|November 14, 2012
Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosisSandrine Marchais-Oberwinkler, Kuiying Xu, Marie Wetzel, et al.
Pageof 5